280 related articles for article (PubMed ID: 22314880)
1. Neoadjuvant chemotherapy for invasive bladder cancer.
Sonpavde G; Sternberg CN
Curr Urol Rep; 2012 Apr; 13(2):136-46. PubMed ID: 22314880
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy preceding cystectomy for bladder cancer.
Sonpavde G; Amiel GE; Mims MP; Hayes TG; Lerner SP
Expert Opin Pharmacother; 2008 Aug; 9(11):1885-93. PubMed ID: 18627327
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy for bladder cancer.
Sonpavde G; Lerner SP
Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours.
Sengeløv L; von der Maase H; Lundbeck F; Barlebo H; Colstrup H; Engelholm SA; Krarup T; Madsen EL; Meyhoff HH; Mommsen S; Nielsen OS; Pedersen D; Steven K; Sørensen B
Acta Oncol; 2002; 41(5):447-56. PubMed ID: 12442921
[TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant chemotherapy: meta-analysis and interpretation of results in bladder cancer].
Pollera CF
Suppl Tumori; 2004; 3(4):S59-61. PubMed ID: 15206215
[No Abstract] [Full Text] [Related]
6. [Systemic therapy of muscle invasive bladder cancer - an update].
Niedersüss-Beke D
Wien Med Wochenschr; 2011 Aug; 161(15-16):371-3. PubMed ID: 21953426
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
Meeks JJ; Bellmunt J; Bochner BH; Clarke NW; Daneshmand S; Galsky MD; Hahn NM; Lerner SP; Mason M; Powles T; Sternberg CN; Sonpavde G
Eur Urol; 2012 Sep; 62(3):523-33. PubMed ID: 22677572
[TBL] [Abstract][Full Text] [Related]
9. Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapy. The Nordic Cooperative Bladder Cancer Study Group.
Hellsten S; Rintala E; Wahlqvist R; Malmström PU
Eur Urol; 1998; 33 Suppl 4():35-8. PubMed ID: 9615209
[No Abstract] [Full Text] [Related]
10. Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
Brant A; Kates M; Chappidi MR; Patel HD; Sopko NA; Netto GJ; Baras AS; Hahn NM; Pierorazio PM; Bivalacqua TJ
Urol Oncol; 2017 Jan; 35(1):34.e17-34.e25. PubMed ID: 27639777
[TBL] [Abstract][Full Text] [Related]
11. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
Blick C; Hall P; Pwint T; Al-Terkait F; Crew J; Powles T; Macaulay V; Munro N; Douglas D; Kilbey N; Protheroe A; Chester JD
Cancer; 2012 Aug; 118(16):3920-7. PubMed ID: 22614698
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of neoadjuvant chemotherapy in invasive bladder cancer.
Cam K; Yildirim A; Ozveri H; Turkeri L; Akdas A
Int Urol Nephrol; 2002; 33(1):49-52. PubMed ID: 12090338
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.
Lancet; 1999 Aug; 354(9178):533-40. PubMed ID: 10470696
[TBL] [Abstract][Full Text] [Related]
14. [Is down-staging of advanced bladder cancer by neoadjuvant chemotherapy possible?--MVEC protocol].
Hoch V; Noll F; Schreiter F
Urologe A; 1992 Jul; 31(4):243-6. PubMed ID: 1514212
[TBL] [Abstract][Full Text] [Related]
15. [Is there an indication for adjuvant or neoadjuvant systemic chemotherapy in bladder cancer?].
Suttmann H; Retz M; Gschwend JE; Stöckle M
Urologe A; 2007 Oct; 46(10):1379-80, 1382-4. PubMed ID: 17805506
[TBL] [Abstract][Full Text] [Related]
16. [ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology].
Pignot G; Houédé N; Roumiguié M; Audenet F; Brunelle S; Colin P; Compérat E; Larré S; Masson-Lecomte A; Neuzillet Y; Xylinas E; Méjean A; Rouprêt M;
Prog Urol; 2018 Oct; 28(12):567-574. PubMed ID: 30205925
[TBL] [Abstract][Full Text] [Related]
17. Radiation, chemotherapy and transurethral surgery: an organ-sparing alternative to the radical cystectomy.
Zietman AL
Front Radiat Ther Oncol; 2002; 36():131-46. PubMed ID: 11842743
[No Abstract] [Full Text] [Related]
18. D2-40/podoplanin expression in cancer stroma by immunohistochemical staining is associated with poor prognosis in bladder cancer patients after radical cystectomy.
Okajima E; Tomizawa M; Shimada K; Negishi T; Nishiyama N; Kitamura H
Urol Oncol; 2020 Oct; 38(10):797.e7-797.e13. PubMed ID: 32576528
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy for urothelial cancer of the bladder--update 2012].
Niegisch G; Lorch A; Albers P
Aktuelle Urol; 2012 Dec; 43(6):412-9. PubMed ID: 23196781
[TBL] [Abstract][Full Text] [Related]
20. [Is neoadjuvant chemotherapy valid in invasive cancer of the bladder?].
Matveev BP; Figurin KM
Urol Nefrol (Mosk); 1998; (6):42-5. PubMed ID: 10051828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]